Offline mode

Anti-human Gd-IgA1 (KM55) Rat IgG

Catalog no.30117066
Quantity / Tests
100 µg
Species / Antigen
Human IgA1 hinge region peptide with GalNAc
Host
Rat
Subclass / Clone
IgG
Type
Monoclonal
Purification
Protein A
Regulatory Status
RUO

"Original article #10777

Galactose-deficient IgA1 (Gd-IgA1) attracts a lot of attentions as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans modified regions exist in the heavy chain hinge region of human IgA1 molecule andGd-IgA1 circulates in the blood stream of patients with the pathological condition of IgAN. The deposition of Gd-IgA1 in glomeruli is considered to be involved in IgAN (Multi-hit Hypothesis of Gd-IgA1). The measuring system using snail (Helix aspersa; HAA) lectin that is extracted from snail and Gd-IgA1 ELISA (Code: 27600 Gd-IgA1 (Galactose-deficient IgA1) Assay Kit using this antibody (KM55) have been used in numerous studies and it has been suggested that serum levels of Gd-IgA1 in patients with IgAN is significantly elevated compared to the levels of healthy subjects or patients with renal disease other than IgAN in such studies. In addition, this antibody (KM55) can detect Gd-IgA1 in tissue by IHC technique differently from the feature of HAA lectin and it has been revealed that Gd-IgA1 specicillay exists in glomeruli of the patients of IgAN from the studies using this antibody. It has been expected that clinical significance of Gd-IgA1 wil be revealed by further studies using this antibody."

Literature references

  1. Yamasaki K, Suzuki H, Yasutake J, Yamazaki Y, Suzuki Y.
    Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
    Monoclon Antib Immunodiagn Immunother. 2018 Dec;37(6):252-256.
    PubMed ID: 30570353
    Keywords: Unique epitope, KM55 mAb, IgA nephropathy, IgAN, renal biopsy, galactose-deficient IgA1 monoclonal antibody
  2. Suzuki H
    Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis.
    Clin Exp Nephrol. 2019 Jan;23(1):26-31.
    PubMed ID: 29740706
    Keywords: KM55 mAb, IgA nephropathy, IgAN, renal biopsy, galactose-deficient IgA1 monoclonal antibody, immune complexes
  3. Neufeld M, Molyneux K, Pappelbaum KI, Mayer-Hain S, von Hodenberg C, Ehrchen J, Barratt J, Suzuki Y, Sunderkötter C.
    . Galactose deficient IgA1 (GD-IgA1) in skin and serum from patients with skin-limited and systemic IgA Vasculitis.
    J Am Acad Dermatol. 2019 Mar 19. pii: S0190-9622(19)30443-8.
    PubMed ID: 30902725
    Keywords: skin biopsies, KM55-antibody, skin-limited and systemic IgA vasculitis, perivascular Gd-IgA deposition

For Research Use Only. Not for use in diagnostic procedures

Distributed by Tecan, IBL International.

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.